Research / FTI / Fundamental state Inspectable configuration
State dimensions Filing 0001681459-26-000010 General Corporate
Debt relative to revenue 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
4.33% · OPTIONAL · VALID
Capex intensity 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
3.19% · OPTIONAL · VALID
Operating cash generation 90th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
17.77% · OPTIONAL · VALID
Revenue growth 45th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
9.35% · CORE · VALID
Inventory pressure 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
11.61% · OPTIONAL · VALID
Operating margin 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
14.46% · CORE · VALID
R&D intensity 25th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.84% · OPTIONAL · VALID
SBC intensity 89th Own-history percentile · N=9
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.62% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 39 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/8 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/8 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/8 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 8/9 normalized Level 3 Mar 31, 2025 7/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 16.55%
Current 4.33%
Delta -12.22% Capex Intensity Increased
Previous 2.92%
Current 3.19%
Delta 0.27% Cash Generation Decreased
Previous 19.84%
Current 17.77%
Delta -2.07% Growth Decreased
Previous 12.73%
Current 9.35%
Delta -3.38% Inventory Pressure Decreased
Previous 44.80%
Current 11.61%
Delta -33.19% Profitability Decreased
Previous 16.55%
Current 14.46%
Delta -2.09% R And D Intensity Decreased
Previous 0.85%
Current 0.84%
Delta -0.01% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.